AHA 2025 Clinical Insights: Advancing Cardiology Care
Explore concise, expert-led educational activities delivering the latest updates from AHA 2025. Dive into key developments across atrial fibrillation, heart failure, lipid management, and aortic stenosis. Find out how breakthrough science is translating into practical clinical impact.
1-8 of 8
CME/CEEarlier Action, Lasting Impact: Closing the LDL-C Gap in Patients Without a Prior MACE
0.25 credits
Erin Bohula, MD, DPhil
Lawrence Leiter
- AHA 2025 Clinical Insights: Advancing Cardiology Care
Sotagliflozin in HFpEF Without Diabetes: Inside the SOTA-P-CARDIA Trial from AHA 2025
Juan Badimon, PhD, FAHA
- AHA 2025 Clinical Insights: Advancing Cardiology Care
The Lp(a)-Lowering Landscape: Navigating Current and Future Therapeutic Options
Erin Michos
- AHA 2025 Clinical Insights: Advancing Cardiology Care
The LDL-C-Lowering Landscape: Navigating Current and Future Therapeutic Options
Prof. Kausik Ray
- Hyperlipidemia
Primary Results of the VESALIUS-CV Trial: Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke
Erin Bohula, MD, DPhil
Nihar R. Desai, MD, MPH
Matthew Jay Budoff, MD
- Hyperlipidemia
Evolocumab in Patients at High Cardiovascular Risk Without Prior MI or Stroke: Primary Results of the VESALIUS-CV Trial
Lawrence Leiter